Below is Validea's guru fundamental report for IOVANCE BIOTHERAPEUTICS INC (IOVA). Of the 22 guru strategies we follow, IOVA rates highest using our Value Investor model based on the published ...

In trading on Monday, shares of Iovance Biotherapeutics Inc (Symbol: IOVA) entered into oversold territory, hitting an RSI reading of 29.9, after changing hands as low as $5.52 per share.

SG Americas Securities LLC purchased a new position in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) in ...

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) shares hit a new 52-week low during trading on Monday after Piper Sandler lowered their price target on the stock from $10.00 to $7.50.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

As of January 29 at 10:01:28 AM EST. Market Open.

As of January 31 at 2:48:20 PM EST. Market Open.

In recent transactions reported to the Securities and Exchange Commission, Jim Wassil, Chief Operating Officer of Vaxcyte, Inc. (NASDAQ:PCVX), a clinical-stage vaccine company with a market ...

After hours: 7:59:40 p.m. EST ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

B, consensus $1.15B. Maximize Your Portfolio with Data Driven Insights: Leverage the power of TipRanks' Smart Score, a data-driven tool to help you ...